Association and incremental predictive value of preoperative AISI and CALLY for postoperative pulmonary complications after McKeown esophagectomy following neoadjuvant chemoimmunotherapy

新辅助化疗免疫疗法后行McKeown食管切除术后,术前AISI和CALLY对术后肺部并发症的相关性及增量预测价值

阅读:1

Abstract

BACKGROUND: Postoperative pulmonary complications (PPCs) remain a major source of morbidity after McKeown esophagectomy for esophageal squamous cell carcinoma (ESCC), particularly in patients receiving neoadjuvant chemoimmunotherapy (nICT). Readily available preoperative biomarkers may improve risk stratification. This study evaluated the predictive value of the aggregate index of systemic inflammation (AISI), the C-reactive protein-albumin-lymphocyte (CALLY) index, and their combined use for PPCs after McKeown esophagectomy following nICT. METHODS: We retrospectively analyzed 412 consecutive ESCC patients who underwent McKeown esophagectomy after nICT between January 2019 and December 2025. The primary endpoint was PPCs within 30 days after surgery. Univariable and multivariable logistic regression analyses were used to examine associations between preoperative biomarkers and PPCs. A combined AISI-CALLY model was constructed using binary logistic regression, and its predictive performance was assessed by receiver operating characteristic (ROC) analysis, DeLong testing, calibration analysis, and decision curve analysis. Propensity score matching (PSM) was performed as a sensitivity analysis. RESULTS: PPCs occurred in 157 of 412 patients (38.1%). In the fully adjusted model, both AISI and CALLY remained independently associated with PPCs. Higher AISI was associated with increased PPC risk (adjusted odds ratio [aOR] 1.195 per 100-unit increase, 95% CI 1.081-1.321, P < 0.001), whereas higher CALLY was associated with lower risk (aOR 0.926 per 1-unit increase, 95% CI 0.884-0.970, P = 0.001). The biomarker-only AISI-CALLY model achieved an AUC of 0.689, compared with 0.650 for AISI alone and 0.665 for CALLY alone. The final integrated model incorporating clinical variables, AISI, and CALLY showed the best discrimination (AUC 0.712, 95% CI 0.658-0.762) and provided greater net benefit on decision curve analysis. In the matched cohort, both biomarkers remained independently associated with PPCs, although discrimination was attenuated. CONCLUSION: Preoperative AISI and CALLY were independently and complementarily associated with PPCs after McKeown esophagectomy following nICT. Their combined use provided only modest incremental predictive value and may serve as an accessible adjunct, rather than a stand-alone tool, for preoperative PPC risk stratification.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。